Comparing the toxicity and disease control rate of radiotherapy for prostate cancer between salvage settings after high-intensity focused ultrasound therapy and initial settings

Autor: Toshihisa Kuroki, Sunao Shoji, Toyoaki Uchida, Takeshi Akiba, Shigeto Kabuki, Ryuta Nagao, Tsuyoshi Fukuzawa, Yoshitsugu Matsumoto, Tomomi Katsumata, Natsumi Futakami, Tatsuya Mikami, Yoji Nakano, Yuri Toyoda, Tsuyoshi Takazawa, Etsuo Kunieda, Akitomo Sugawara
Rok vydání: 2022
Předmět:
Zdroj: Journal of Radiation Research. 63:675-683
ISSN: 1349-9157
0449-3060
DOI: 10.1093/jrr/rrac039
Popis: The purpose of this retrospective study was to compare the toxicity and disease control rate of radiotherapy for prostate cancer in salvage settings after high-intensity focused ultrasound (HIFU) therapy (HIFU cohort) with those in radical settings (non-HIFU cohort). From 2012 to 2020, 215 patients were identified for this study and 17 were treated in the salvage settings after HIFU. The median follow-up time was 34.5 months (range: 7–102 months, inter-quartile range [IQR]: 16–64 months). Genitourinary (GU) and gastrointestinal (GI) adverse events were evaluated in acute and late periods with Common Terminology Criteria for Adverse Events version 5, and the rates of biochemical-clinical failure free survival (BCFS) and overall survival (OS) were estimated. The cumulative incidence of late GU Grade 2 or greater toxicity after five years was significantly different between the non-HIFU and HIFU cohorts with rates of 7.3% and 26.2%, respectively (P = 0.03). Regarding GI Grade 2 or greater toxicity, there was no significant difference between the two cohorts. The 5y-BCFS was 84.2% in the non-HIFU cohort and 69.5% in the HIFU cohort with no significant difference (P = 0.10) and the 5y-OS was 95.9% and 92.3%, respectively (P = 0.47). We concluded that the possibility of increased late GU Grade 2 or greater should be considered when applying salvage radiotherapy for local recurrence after HIFU.
Databáze: OpenAIRE
Externí odkaz: